|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects export multiple interactions |
ISO |
ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog Glutathione promotes the reaction [ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog] |
CTD |
PMID:15766272 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
increases expression decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of ABL1 mRNA 4-Nitroquinoline-1-oxide results in decreased expression of ABL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of ACSL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of ACSL6 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased phosphorylation of AKT1 protein |
CTD |
PMID:37406968 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BCL2A1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BSCL2 mRNA |
CTD |
PMID:22003191 |
|
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of BUB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL4 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL5 mRNA 4-Nitroquinoline-1-oxide results in decreased expression of CCL5 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CCL7 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNA2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA] 4-Nitroquinoline-1-oxide results in increased expression of CCND1 mRNA |
CTD |
PMID:20043093 PMID:27148699 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CCNE2 mRNA 4-Nitroquinoline-1-oxide results in increased expression of CCNE2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cd59b |
CD59b molecule |
multiple interactions |
EXP |
[4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein |
CTD |
PMID:19965957 PMID:20202993 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CDC25C mRNA 4-Nitroquinoline-1-oxide results in increased expression of CDC25C mRNA |
CTD |
PMID:22561872 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc7 |
cell division cycle 7 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CDC7 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CPT1B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide co-treated with Arecoline] results in increased expression of CRYAB protein |
CTD |
PMID:19840781 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Cryz |
crystallin zeta |
increases activity multiple interactions |
EXP |
4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein] |
CTD |
PMID:12566915 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CSF2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctsd |
cathepsin D |
increases activity multiple interactions |
EXP |
4-Nitroquinoline-1-oxide results in increased activity of CTSD protein geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CTSD protein] |
CTD |
PMID:23499697 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cttn |
cortactin |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CTTN mRNA; 4-Nitroquinoline-1-oxide results in increased expression of CTTN protein |
CTD |
PMID:27148699 |
|
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of CXCL10 mRNA 4-Nitroquinoline-1-oxide results in increased expression of CXCL10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL11 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL1 mRNA |
CTD |
PMID:22561872 PMID:27148699 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL5 mRNA |
CTD |
PMID:27148699 |
|
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCL9 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of CXCR3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases activity multiple interactions |
EXP |
4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein] |
CTD |
PMID:23499697 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
E2f3 |
E2F transcription factor 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of E2F3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of EPCAM mRNA |
CTD |
PMID:27148699 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] |
CTD |
PMID:32942007 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions increases expression |
ISO |
4-Nitroquinoline-1-oxide promotes the reaction [Glucose results in increased expression of GPX4 protein] 4-Nitroquinoline-1-oxide results in increased expression of GPX4 protein |
CTD |
PMID:32942007 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
H2ax |
H2A.X variant histone |
increases expression increases phosphorylation |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of H2AX protein 4-Nitroquinoline-1-oxide results in increased phosphorylation of H2AX protein |
CTD |
PMID:32087850 PMID:34510228 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression multiple interactions |
ISO |
4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein 4-Nitroquinoline-1-oxide inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]; [4-Nitroquinoline-1-oxide results in increased susceptibility to Glucose] which results in increased expression of HMOX1 protein; Glucose inhibits the reaction [4-Nitroquinoline-1-oxide affects the expression of HMOX1 protein] |
CTD |
PMID:32942007 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
ISO |
4-Nitroquinoline-1-oxide results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:26362870 PMID:28454271 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA; [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA]; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] |
CTD |
PMID:20043093 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO |
[4-Nitroquinoline-1-oxide co-treated with Arecoline] results in increased expression of HSPB1 protein |
CTD |
PMID:19840781 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Ifnb1 |
interferon beta 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IFNB1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IFNG mRNA 4-Nitroquinoline-1-oxide results in increased expression of IFNG mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL12A mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IL12B mRNA 4-Nitroquinoline-1-oxide results in increased expression of IL12B mRNA |
CTD |
PMID:22561872 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il19 |
interleukin 19 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL19 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO EXP |
4-Nitroquinoline-1-oxide results in increased expression of IL1B mRNA 4-Nitroquinoline-1-oxide results in increased expression of IL1B protein geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of IL1B protein] [Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of IL1B mRNA |
CTD |
PMID:22561872 PMID:28397014 PMID:37406968 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il23a |
interleukin 23 subunit alpha |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of IL23A mRNA 4-Nitroquinoline-1-oxide results in increased expression of IL23A mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL24 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of IL6 mRNA [Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of IL6 mRNA |
CTD |
PMID:22561872 PMID:37406968 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased expression of JUN mRNA |
CTD |
PMID:37406968 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk6 |
mitogen-activated protein kinase 6 |
multiple interactions increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of and results in increased phosphorylation of MAPK6 protein 4-Nitroquinoline-1-oxide results in increased expression of MAPK6 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression multiple interactions |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein] |
CTD |
PMID:37406968 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP10 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
decreases expression increases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of MMP12 mRNA 4-Nitroquinoline-1-oxide results in increased expression of MMP12 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of MMP13 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of MMP9 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein]; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein] |
CTD |
PMID:12566915 PMID:28397014 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases reduction decreases response to substance multiple interactions decreases activity |
ISO EXP |
NQO1 protein results in increased reduction of 4-Nitroquinoline-1-oxide NQO1 protein results in decreased susceptibility to 4-Nitroquinoline-1-oxide geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in decreased activity of NQO1 protein] |
CTD |
PMID:9310146 PMID:23499697 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Osm |
oncostatin M |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of OSM mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
Osmr |
oncostatin M receptor |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of OSMR mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
multiple interactions increases mutagenesis |
EXP ISO |
4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein 4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA; 4-Nitroquinoline-1-oxide results in increased mutagenesis of PIGA gene |
CTD |
PMID:19965957 PMID:20202993 PMID:22923490 PMID:29362862 |
|
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
[Ethanol co-treated with 4-Nitroquinoline-1-oxide] results in increased phosphorylation of PIK3R1 protein |
CTD |
PMID:37406968 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions increases activity |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of POR protein] |
CTD |
PMID:23499697 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppbp |
pro-platelet basic protein |
increases expression decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of PPBP mRNA 4-Nitroquinoline-1-oxide results in decreased expression of PPBP mRNA |
CTD |
PMID:22561872 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases response to substance |
ISO EXP |
[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA; nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 mRNA; 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein Zinc deficiency inhibits the reaction [PTGS2 gene mutant form results in decreased susceptibility to 4-Nitroquinoline-1-oxide] geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein] |
CTD |
PMID:20043093 PMID:20857495 PMID:22561872 PMID:28397014 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of PTHLH mRNA |
CTD |
PMID:27148699 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization multiple interactions |
ISO EXP |
4-Nitroquinoline-1-oxide affects the localization of RELA protein 4-Nitroquinoline-1-oxide results in increased expression of and affects the localization of RELA protein; geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of and affects the localization of RELA protein] |
CTD |
PMID:22561872 PMID:28397014 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of RRM2 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Tk1 |
thymidine kinase 1 |
increases mutagenesis |
ISO |
4-Nitroquinoline-1-oxide results in increased mutagenesis of TK1 gene |
CTD |
PMID:28454271 PMID:32087850 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of TNF protein] |
CTD |
PMID:28397014 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tp53 |
tumor protein p53 |
affects response to substance decreases expression increases expression |
ISO EXP |
TRP53 protein affects the susceptibility to 4-Nitroquinoline-1-oxide 4-Nitroquinoline-1-oxide results in decreased expression of TP53 protein 4-Nitroquinoline-1-oxide results in increased expression of TP53 protein |
CTD |
PMID:16543248 PMID:20599846 PMID:32087850 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Traf1 |
TNF receptor-associated factor 1 |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of TRAF1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
increases expression |
ISO |
4-Nitroquinoline-1-oxide results in increased expression of WEE1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wnt1 |
Wnt family member 1 |
increases expression |
EXP |
4-Nitroquinoline-1-oxide results in increased expression of WNT1 mRNA |
CTD |
PMID:19931241 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wnt5a |
Wnt family member 5A |
increases expression |
EXP |
4-Nitroquinoline-1-oxide results in increased expression of WNT5A mRNA |
CTD |
PMID:19931241 |
|
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Xcl1 |
X-C motif chemokine ligand 1 |
decreases expression |
ISO |
4-Nitroquinoline-1-oxide results in decreased expression of XCL1 mRNA |
CTD |
PMID:22561872 |
|
NCBI chr13:77,248,687...77,252,343
Ensembl chr13:77,248,717...77,252,329
|
|